Target intelligence / Profile preview

Phospholipid bilayer of vascular endothelial cell membranes

Molecular classification
Cellular component, Lipid bilayer, Biological membrane
01

Overview

The phospholipid bilayer of vascular endothelial cell membranes is a complex lipid-protein assembly that serves as the primary barrier between the blood and underlying tissues (Pober & Sessa, 2007). It plays a vital role in vascular homeostasis by regulating selective permeability, leukocyte trafficking, and signal transduction through various membrane-bound receptors (Aird, 2007). In healthy physiological states, the bilayer maintains an asymmetric distribution of phospholipids, with anionic species like phosphatidylserine (PS) restricted to the inner leaflet (Bevers & Williamson, 2016). However, in pathological conditions such as cancer, inflammation, or viral infection, this asymmetry is disrupted, leading to the exposure of PS on the outer surface of the endothelial cells (Gerber et al., 2011). This externalization provides a unique therapeutic window, allowing drugs like Bavituximab to selectively bind to the tumor-associated or infected vasculature and induce immune-mediated destruction. Beyond serving as a docking site for targeted therapies, the physical state of the membrane—including its fluidity and lipid composition—is a target for agents aimed at stabilizing the endothelium in cardiovascular diseases (Escribá et al., 2008).

Other names
Endothelial cell membraneVascular endothelial membraneEndothelial lipid bilayerVascular endothelial surface
02

Mechanism of action

Binding to externalized anionic phospholipids (e.g., phosphatidylserine) to induce antibody-dependent cellular cytotoxicity (ADCC) or modulating membrane fluidity and permeability to stabilize vascular function.

03

Biological functions

Selective permeabilitySignal transductionVascular homeostasisCell adhesionVessel wall integrityLeukocyte trafficking
04

Disease associations

CancerCardiovascular diseaseInflammationAtherosclerosisSepsisThrombosisViral infection
05

Safety considerations

Non-specific membrane disruptionSystemic coagulopathyOff-target effects on non-vascular membranesInfusion-related reactionsPotential for hemolysis
06

Interacting drugs

Bavituximab

5 more in the full profile.

07

Biomarkers

Endothelial microparticles (EMPs)Annexin V binding levelsCirculating endothelial cells (CECs)Soluble VCAM-1

Beyond the preview

Go deeper on Phospholipid bilayer of vascular endothelial cell membranes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phospholipid bilayer of vascular endothelial cell membranes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call